MetaCap

Gain Therapeutics (GANX) News

NASDAQ: GANXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.9994-0.0506 (-4.82%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

GANX news summary

We found 5 recent headlines mentioning Gain Therapeutics (GANX): 2 in the past week and 5 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, GANX is down 4.82% at $0.9994. The most recent story, "Gain Therapeutics, Inc. Reports Phase 1b Clinical Data for Rexaceract", was published by Nasdaq on Nov 17, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Gain Therapeutics headlines

Stocks mentioned alongside GANX

Compare GANX